{"id":167390,"date":"2025-03-14T07:41:13","date_gmt":"2025-03-14T11:41:13","guid":{"rendered":"https:\/\/44.250.171.167\/?p=167390"},"modified":"2025-03-14T07:41:13","modified_gmt":"2025-03-14T11:41:13","slug":"caplin-point-laboratories-ltd-q3fy25-17-rise-in-profits","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/caplin-point-laboratories-ltd-q3fy25-17-rise-in-profits\/","title":{"rendered":"Caplin Point Laboratories Ltd Q3FY25; 17% rise in Profits"},"content":{"rendered":"<p>Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&amp;D, clinical research with presence in Latin America, Africa, USA and other nations.<\/p>\n<p>Financial Results:<\/p>\n<p>Caplin Point Laboratories Ltd reported Revenues for Q3FY25 of \u20b9493.00 Crores up from \u20b9436.00 Crore year on year, a rise of 13.07%.<\/p>\n<p>Total Expenses for Q3FY25 of \u20b9347.00 Crores up from \u20b9307.00 Crores year on year, a rise of 13.03%.<\/p>\n<p>Consolidated Net Profit of \u20b9140.00 Crores up 16.67% from \u20b9120.00 Crores in the same quarter of the previous year.<\/p>\n<p>The Earnings per Share is \u20b918.28, up 18.47% from \u20b915.43 in the same quarter of the previous year.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-167391\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/O-4.png\" alt=\"\" width=\"1489\" height=\"1817\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/O-4.png 1489w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/O-4-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/O-4-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/O-4-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/O-4-1259x1536.png 1259w\" sizes=\"auto, (max-width: 1489px) 100vw, 1489px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&amp;D, clinical research with presence in Latin America, Africa, USA and other nations. Financial Results: Caplin Point Laboratories Ltd reported Revenues for Q3FY25 of \u20b9493.00 Crores up from \u20b9436.00 Crore year on year, a rise of 13.07%. Total Expenses for [&hellip;]<\/p>\n","protected":false},"author":1932,"featured_media":167391,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392],"tags":[8759],"class_list":["post-167390","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","tag-clinical-research"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/O-4.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":165984,"url":"https:\/\/alphastreet.com\/india\/caplin-point-laboratories-ltd-q2fy25-13-rise-in-profits\/","url_meta":{"origin":167390,"position":0},"title":"Caplin Point Laboratories Ltd Q2FY25; 13% rise in Profits","author":"Divyansh_Kasana","date":"December 10, 2024","format":false,"excerpt":"Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&D, clinical research with presence in Latin America, Africa, USA and other nations. Financial Results: Caplin Point Laboratories Ltd reported Revenues for Q2FY25 of \u20b9483.00 Crores up from \u20b9410.00 Crore year on year, a rise\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/JJJ.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/JJJ.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/JJJ.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/JJJ.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/JJJ.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/JJJ.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":168907,"url":"https:\/\/alphastreet.com\/india\/caplin-point-laboratories-ltd-q4fy25-20-rise-in-profits\/","url_meta":{"origin":167390,"position":1},"title":"Caplin Point Laboratories Ltd Q4FY25; 20% rise in Profits","author":"Divyansh_Kasana","date":"June 26, 2025","format":false,"excerpt":"Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&D, clinical research with presence in Latin America, Africa, USA and other nations. Financial Results: Caplin Point Laboratories Ltd reported Revenues for Q4FY25 of \u20b9502.00 Crores up from \u20b9453.00 Crore year on year, a rise\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-17.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-17.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-17.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-17.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-17.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-17.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":151610,"url":"https:\/\/alphastreet.com\/india\/caplin-point-laboratories-ltd-q1fy24-21-rise-in-profits\/","url_meta":{"origin":167390,"position":2},"title":"Caplin Point Laboratories Ltd Q1FY24; 21% rise in Profits","author":"Divyansh_Kasana","date":"August 7, 2023","format":false,"excerpt":"Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&D, clinical research with presence in Latin America, Africa, USA and other nations. Financial Results: Caplin Point Laboratories Ltd reported Revenues for Q1FY24 of \u20b9395.00 Crores up from \u20b9346.00 Crore year on year, a rise\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-313.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-313.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-313.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-313.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-313.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-313.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":161801,"url":"https:\/\/alphastreet.com\/india\/caplin-point-laboratories-ltd-q4fy24-20-rise-in-profits\/","url_meta":{"origin":167390,"position":3},"title":"Caplin Point Laboratories Ltd Q4FY24; 20% rise in Profits","author":"Divyansh_Kasana","date":"June 3, 2024","format":false,"excerpt":"Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&D, clinical research with presence in Latin America, Africa, USA and other nations. Financial Results: Caplin Point Laboratories Ltd reported Revenues for Q4FY24 of \u20b9453.00 Crores up from \u20b9389.00 Crore year on year, a rise\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-22.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-22.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-22.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-22.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-22.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-22.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":157158,"url":"https:\/\/alphastreet.com\/india\/caplin-point-laboratories-ltd-q4fy23-25-rise-in-profits\/","url_meta":{"origin":167390,"position":4},"title":"Caplin Point Laboratories Ltd Q4FY23; 25% rise in Profits","author":"Divyansh_Kasana","date":"December 7, 2023","format":false,"excerpt":"Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&D, clinical research with presence in Latin America, Africa, USA and other nations. Financial Results: Caplin Point Laboratories Ltd reported Revenues for Q4FY23 of \u20b9389.00 Crores up from \u20b9339.00 Crore year on year, a rise\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-50.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-50.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-50.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-50.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-50.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-50.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":167573,"url":"https:\/\/alphastreet.com\/india\/divis-laboratories-ltd-q3fy25-65-rise-in-profits\/","url_meta":{"origin":167390,"position":5},"title":"Divis Laboratories Ltd Q3FY25; 65% rise in Profits","author":"Divyansh_Kasana","date":"March 26, 2025","format":false,"excerpt":"Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients Financial Results: Divis Laboratories Ltd reported Revenues for Q3FY25 of \u20b92,319.00 Crores up from \u20b91,855.00 Crore year on year, a rise of 25.01%. Total Expenses for Q3FY25 of \u20b91,675.00 Crores up from \u20b91,461.00 Crores year on\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-8.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-8.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-8.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-8.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-8.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-8.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/167390","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=167390"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/167390\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/167391"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=167390"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=167390"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=167390"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}